Establishment Labs Holdings Inc. (ESTA)

CR — Healthcare Sector
Peers: KIDS  ITGR  TMCI  CNMD  NPCE  INGN  SRDX  LUNG  APYX  SGHT  OSA  LIVN  ELMD  GKOS  FNA 

Automate Your Wheel Strategy on ESTA

With Tiblio's Option Bot, you can configure your own wheel strategy including ESTA - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol ESTA
  • Rev/Share 5.7754
  • Book/Share 1.3079
  • PB 26.3178
  • Debt/Equity 0.0987
  • CurrentRatio 3.3561
  • ROIC -0.2164

 

  • MktCap 995024960.0
  • FreeCF/Share -2.3588
  • PFCF -14.3115
  • PE -11.3862
  • Debt/Assets 0.0114
  • DivYield 0
  • ROE -2.1043

 

  • Rating C+
  • Score 2
  • Recommendation Sell
  • P/E Score 1
  • DCF Score 5
  • P/B Score 1
  • D/E Score 3

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
Initiation ESTA BTIG Research -- Buy -- $62 May 16, 2025
Upgrade ESTA Needham Hold Buy -- $48 May 14, 2025
Initiation ESTA Needham -- Hold -- -- April 14, 2025

News

Establishment Labs Holdings Inc. (ESTA) Reports Q1 Loss, Lags Revenue Estimates
ESTA
Published: May 07, 2025 by: Zacks Investment Research
Sentiment: Negative

Establishment Labs Holdings Inc. (ESTA) came out with a quarterly loss of $0.70 per share versus the Zacks Consensus Estimate of a loss of $0.83. This compares to loss of $0.58 per share a year ago.

Read More
image for news Establishment Labs Holdings Inc. (ESTA) Reports Q1 Loss, Lags Revenue Estimates
Establishment Labs® Announces Meghan Trainor as Brand Partner Following Her Breast Augmentation with Motiva Implants®
ESTA
Published: March 06, 2025 by: PRNewsWire
Sentiment: Neutral

The campaign is the first-of-its-kind partnership and follows the US FDA approval of Motiva Implants® NEW YORK , March 6, 2025 /PRNewswire/ -- Establishment Labs® Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, today announced a partnership with GRAMMY Award-winning hitmaker Meghan Trainor. Meghan recently received Motiva Implants® after careful consideration and research.

Read More
image for news Establishment Labs® Announces Meghan Trainor as Brand Partner Following Her Breast Augmentation with Motiva Implants®
Establishment Labs Holdings Inc. (ESTA) Q4 2024 Earnings Call Transcript
ESTA
Published: February 26, 2025 by: Seeking Alpha
Sentiment: Neutral

Establishment Labs Holdings Inc. (NASDAQ:ESTA ) Q4 2024 Earnings Conference Call February 26, 2025 4:30 PM ET Company Participants Raj Denhoy - CFO Juan Chacón-Quirós - CEO Peter Caldini - President Conference Call Participants Anthony Petrone - Mizuho Group Allen Gong - JPMorgan Josh Jennings - TD Cowen Marie Thibault - BTIG Joanne Wuensch - Citibank Matt Taylor - Jefferies Harrison Parsons - Stephens Inc Operator Good afternoon. Welcome to Establishment Labs Fourth Quarter 2024 Earnings Call.

Read More
image for news Establishment Labs Holdings Inc. (ESTA) Q4 2024 Earnings Call Transcript
Establishment Labs to Announce Fourth Quarter 2024 Financial Results on February 26
ESTA
Published: February 14, 2025 by: Business Wire
Sentiment: Neutral

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the quarter ended December 31, 2024, after the market closes on Wednesday, February 26, 2025, and will host a conference call at 4:30 pm ET that day to discuss those results. To participate in the conference call, dial (877) 407-8037 (U.S.

Read More
image for news Establishment Labs to Announce Fourth Quarter 2024 Financial Results on February 26

About Establishment Labs Holdings Inc. (ESTA)

  • IPO Date 2018-07-19
  • Website https://www.establishmentlabs.com
  • Industry Medical - Devices
  • CEO Mr. Fillipo Peter Caldini
  • Employees 1034

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander, as well as distributes Puregraft line of products for autologous adipose tissue harvesting and redistribution. The company sells its products through exclusive distributors and direct sales force in Europe, Latin America, the Asia-Pacific, and internationally. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.